Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction Enfermedad neumocócica y vacunación antineumocócica en las Américas: programa de acción para la introducción acelerada de una vacuna
This piece summarizes the presentations and discussions at a meeting on pneumococcal disease surveillance in the Americas that was held in Mexico City, Mexico, on 2 November 2004. This meeting was organized by the Pan American Health Organization (PAHO) and the Pneumococcal Vaccines Accelerated Deve...
Main Authors: | , , , , |
---|---|
Format: | Article in Journal/Newspaper |
Language: | English Spanish Portuguese |
Published: |
Pan American Health Organization
2006
|
Subjects: | |
Online Access: | https://doaj.org/article/80fe8e32e7284403af2c7ab93f38852e |
id |
ftdoajarticles:oai:doaj.org/article:80fe8e32e7284403af2c7ab93f38852e |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:80fe8e32e7284403af2c7ab93f38852e 2023-05-15T15:17:12+02:00 Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction Enfermedad neumocócica y vacunación antineumocócica en las Américas: programa de acción para la introducción acelerada de una vacuna Salvador Garcia Orin S. Levine Thomas Cherian Jean Marc Gabastou Jon Andrus 2006-05-01T00:00:00Z https://doaj.org/article/80fe8e32e7284403af2c7ab93f38852e EN ES PT eng spa por Pan American Health Organization http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000500007 https://doaj.org/toc/1020-4989 https://doaj.org/toc/1680-5348 1020-4989 1680-5348 https://doaj.org/article/80fe8e32e7284403af2c7ab93f38852e Revista Panamericana de Salud Pública, Vol 19, Iss 5, Pp 340-348 (2006) Streptococcus pneumoniae vacunas antineumocócicas programas de inmunización costo de los medicamentos Américas pneumococcal vaccines immunization programs drug costs Americas Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 article 2006 ftdoajarticles 2022-12-30T22:31:52Z This piece summarizes the presentations and discussions at a meeting on pneumococcal disease surveillance in the Americas that was held in Mexico City, Mexico, on 2 November 2004. This meeting was organized by the Pan American Health Organization (PAHO) and the Pneumococcal Vaccines Accelerated Development and Introduction Plan (PneumoADIP) of the Global Alliance for Vaccines and Immunization (GAVI). The meeting participants reviewed the status of pneumococcal disease surveillance in the Region of the Americas, estimates of the burden of pneumococcal disease, the distribution of Streptococcus pneumoniae serotypes that cause invasive disease, the status of pneumococcal vaccine introduction, health economic analyses, and financial issues related to vaccine introduction. The meeting participants also worked to identify the next steps for generating the critical information needed to help make decisions on pneumococcal vaccine introduction. Coordinated pneumococcal disease surveillance for the Region of the Americas dates back to the 1993 establishment by PAHO of the Regional System for Vaccines (RSV) project for surveillance of bacterial meningitis and pneumonia, including pneumococcal disease. Surveillance data from the RSV indicate that the distribution of major serotypes in the Americas has been stable over time (but that antibiotic resistance is increasing), with serotype 14 being the leading serotype isolated in most countries participating in RSV. Based on local serotype data from six of the RSV countries (Argentina, Brazil, Chile, Colombia, Mexico, and Uruguay), the 7-valent vaccine would cover 65% of serotypes, the 9-valent vaccine would cover 77%, and the 11-valent vaccine would cover 83%. Este trabajo resume las presentaciones y los debates que hubo en una reunión sobre la vigilancia de las enfermedades neumocócicas en las Américas, celebrada en la ciudad de México, México, el 2 de noviembre de 2004. La reunión la habían organizado la Organización Panamericana de la Salud (OPS) y el Plan para el ... Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Argentina Uruguay |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English Spanish Portuguese |
topic |
Streptococcus pneumoniae vacunas antineumocócicas programas de inmunización costo de los medicamentos Américas pneumococcal vaccines immunization programs drug costs Americas Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
spellingShingle |
Streptococcus pneumoniae vacunas antineumocócicas programas de inmunización costo de los medicamentos Américas pneumococcal vaccines immunization programs drug costs Americas Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Salvador Garcia Orin S. Levine Thomas Cherian Jean Marc Gabastou Jon Andrus Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction Enfermedad neumocócica y vacunación antineumocócica en las Américas: programa de acción para la introducción acelerada de una vacuna |
topic_facet |
Streptococcus pneumoniae vacunas antineumocócicas programas de inmunización costo de los medicamentos Américas pneumococcal vaccines immunization programs drug costs Americas Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
description |
This piece summarizes the presentations and discussions at a meeting on pneumococcal disease surveillance in the Americas that was held in Mexico City, Mexico, on 2 November 2004. This meeting was organized by the Pan American Health Organization (PAHO) and the Pneumococcal Vaccines Accelerated Development and Introduction Plan (PneumoADIP) of the Global Alliance for Vaccines and Immunization (GAVI). The meeting participants reviewed the status of pneumococcal disease surveillance in the Region of the Americas, estimates of the burden of pneumococcal disease, the distribution of Streptococcus pneumoniae serotypes that cause invasive disease, the status of pneumococcal vaccine introduction, health economic analyses, and financial issues related to vaccine introduction. The meeting participants also worked to identify the next steps for generating the critical information needed to help make decisions on pneumococcal vaccine introduction. Coordinated pneumococcal disease surveillance for the Region of the Americas dates back to the 1993 establishment by PAHO of the Regional System for Vaccines (RSV) project for surveillance of bacterial meningitis and pneumonia, including pneumococcal disease. Surveillance data from the RSV indicate that the distribution of major serotypes in the Americas has been stable over time (but that antibiotic resistance is increasing), with serotype 14 being the leading serotype isolated in most countries participating in RSV. Based on local serotype data from six of the RSV countries (Argentina, Brazil, Chile, Colombia, Mexico, and Uruguay), the 7-valent vaccine would cover 65% of serotypes, the 9-valent vaccine would cover 77%, and the 11-valent vaccine would cover 83%. Este trabajo resume las presentaciones y los debates que hubo en una reunión sobre la vigilancia de las enfermedades neumocócicas en las Américas, celebrada en la ciudad de México, México, el 2 de noviembre de 2004. La reunión la habían organizado la Organización Panamericana de la Salud (OPS) y el Plan para el ... |
format |
Article in Journal/Newspaper |
author |
Salvador Garcia Orin S. Levine Thomas Cherian Jean Marc Gabastou Jon Andrus |
author_facet |
Salvador Garcia Orin S. Levine Thomas Cherian Jean Marc Gabastou Jon Andrus |
author_sort |
Salvador Garcia |
title |
Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction Enfermedad neumocócica y vacunación antineumocócica en las Américas: programa de acción para la introducción acelerada de una vacuna |
title_short |
Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction Enfermedad neumocócica y vacunación antineumocócica en las Américas: programa de acción para la introducción acelerada de una vacuna |
title_full |
Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction Enfermedad neumocócica y vacunación antineumocócica en las Américas: programa de acción para la introducción acelerada de una vacuna |
title_fullStr |
Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction Enfermedad neumocócica y vacunación antineumocócica en las Américas: programa de acción para la introducción acelerada de una vacuna |
title_full_unstemmed |
Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction Enfermedad neumocócica y vacunación antineumocócica en las Américas: programa de acción para la introducción acelerada de una vacuna |
title_sort |
pneumococcal disease and vaccination in the americas: an agenda for accelerated vaccine introduction enfermedad neumocócica y vacunación antineumocócica en las américas: programa de acción para la introducción acelerada de una vacuna |
publisher |
Pan American Health Organization |
publishDate |
2006 |
url |
https://doaj.org/article/80fe8e32e7284403af2c7ab93f38852e |
geographic |
Arctic Argentina Uruguay |
geographic_facet |
Arctic Argentina Uruguay |
genre |
Arctic |
genre_facet |
Arctic |
op_source |
Revista Panamericana de Salud Pública, Vol 19, Iss 5, Pp 340-348 (2006) |
op_relation |
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000500007 https://doaj.org/toc/1020-4989 https://doaj.org/toc/1680-5348 1020-4989 1680-5348 https://doaj.org/article/80fe8e32e7284403af2c7ab93f38852e |
_version_ |
1766347462311673856 |